BioXcel Therapeutics to Expand Study of BXCL701 into Multiple Advanced Solid Tumor TypesGlobeNewsWire • 12/11/19
BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/14/19
BioXcel Therapeutics Announces Award of Grant by U.S. Department of Defense’s (“DoD”) Congressionally Directed Medical Research Programs (“CDMRP”) for Development of BXCL501GlobeNewsWire • 08/20/19
BioXcel Therapeutics, Inc. (BTAI) CEO Vimal Mehta on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/12/19